Stockholders’ Equity (Details Narrative) - USD ($)
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
9 Months Ended |
10 Months Ended |
12 Months Ended |
|
|
|
|
Jul. 15, 2025 |
Feb. 07, 2025 |
Mar. 02, 2023 |
Jan. 23, 2024 |
Jun. 23, 2023 |
Apr. 30, 2022 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Mar. 20, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Sep. 30, 2024 |
Nov. 14, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Mar. 08, 2023 |
Dec. 31, 2022 |
May 23, 2022 |
Oct. 01, 2019 |
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,200,000
|
|
|
|
Common stock issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22,500
|
Common stock , per value |
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
$ 0.00001
|
|
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.21
|
|
Proceeds from issuance of common stock |
$ 103,912
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of shares, shares |
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
Conversion of shares, Value |
|
|
$ 390,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,622,119
|
|
|
|
|
Expiration date |
|
|
|
|
|
Jun. 30, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued |
|
|
|
|
|
|
|
|
|
|
|
0
|
22,471
|
|
|
674,146
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for services, shares |
|
|
|
|
|
|
1,559
|
|
|
315
|
|
2,061
|
464
|
|
|
48,568
|
52,375
|
|
|
|
|
Stock issued for services, amount |
|
|
|
|
|
|
$ 6,000
|
|
|
$ 6,000
|
|
$ 12,000
|
$ 14,000
|
|
|
$ 26,000
|
$ 44,000
|
|
|
|
|
Equity Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
$ 3.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
$ 1.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration date |
|
|
|
|
Jun. 23, 2033
|
|
|
Mar. 31, 2035
|
|
|
|
Jun. 30, 2035
|
Jun. 30, 2034
|
Sep. 30, 2034
|
Nov. 14, 2034
|
Dec. 31, 2034
|
|
|
|
|
|
Options granted |
|
|
|
|
825,000
|
|
|
2,524
|
|
|
|
6,944
|
1,012
|
74,744
|
15,728
|
13,632
|
|
|
|
|
|
Stock options valued |
|
|
|
|
|
|
|
$ 24,612
|
|
|
|
$ 24,778
|
$ 16,625
|
$ 16,618
|
$ 4,125
|
$ 12,289
|
$ 1,035,273
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
4.3908%
|
|
|
|
4.39%
|
4.40%
|
3.79%
|
4.44%
|
4.58%
|
5.41%
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
148.00%
|
|
|
|
161.00%
|
188.00%
|
184.00%
|
156.00%
|
146.00%
|
176.00%
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 3.60
|
$ 9.90
|
|
$ 0.55
|
|
$ 3.60
|
$ 0.55
|
$ 0.22
|
$ 0.27
|
$ 0.92
|
$ 1.26
|
|
|
|
|
Number of shares granted |
|
|
|
|
|
|
|
|
|
|
|
9,468
|
40,604
|
|
|
1,322,231
|
825,000
|
|
|
|
|
Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
6,201,377
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
$ 9,476,508
|
|
|
|
|
|
|
$ 3,511,042
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales Agreement [Member] | At The Market Issuance [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 3,511,040
|
$ 2,176,556
|
|
|
|
|
|
|
|
|
Placement agent fees |
|
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
|
|
|
Sales commissions |
|
|
|
|
|
|
|
|
|
|
|
$ 87,256
|
$ 54,399
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
206,713
|
72,058
|
|
|
|
|
|
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
$ 272.26
|
|
|
272.26
|
|
$ 272.26
|
$ 272.26
|
|
|
$ 272.26
|
$ 291.05
|
|
$ 9.63
|
|
|
7 accredited investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
Placement agent fees |
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
$ 100,000
|
|
|
|
|
|
Altitude Capital Group LLC [Member] | Placement Agent Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Placement agent agreement description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
the
Company entered into a Placement Agent Agreement with Altitude Capital Group, LLC, as placement agent (“Altitude Capital”
or the “Placement Agent”). The Company’s Non-Executive Chairman of the Board owns 10% of Altitude Capital. Pursuant
to the Placement Agent Agreement, at closing, Altitude Capital was paid a cash commission equal to 10% of the gross proceeds received
by the Company, plus 20% warrant coverage, providing Altitude Capital with the right to purchase 112,353 shares of Common Stock at $1.78
per share through February 2, 2030 (the “Placement Agent Warrants”).
|
|
|
|
|
|
Craig Hallum Capital Group LLC [Member] | Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,758,057
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,546,949
|
|
|
|
|
|
Placement agent fees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
|
|
|
|
Sales commissions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 288,674
|
|
|
|
|
|
Altitude Capital [Member] | Placement Agent Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Placement agent agreement description |
|
|
|
|
|
|
|
|
|
|
|
Company entered into a Placement Agent Agreement with Altitude Capital Group, LLC, as placement agent (“Altitude Capital”
or the “Placement Agent”). The Company’s Non-Executive Chairman of the Board owns 10% of Altitude Capital. Pursuant
to the Placement Agent Agreement, at closing, Altitude Capital was paid a cash commission equal to 10% of the gross proceeds received
by the Company, plus 20% warrant coverage, providing Altitude Capital with the right to purchase 3,745 shares (112,353 prior to the Reverse
Stock Split) of Common Stock at $53.40 per share ($1.78 prior to the Reverse Stock Split) through February 2, 2030 (the “Placement
Agent Warrants”).
|
|
|
|
|
|
|
|
|
|
Plan 2022 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,265,516
|
|
|
|
|
|
Number of shares authorized |
|
|
|
1,060,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issuance |
|
|
|
|
|
|
108,851
|
|
|
|
|
108,851
|
|
|
|
|
|
|
|
|
|
Number of shares authorized |
|
|
|
35,349
|
|
|
|
95,721
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price |
|
|
|
$ 63.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expiration date |
|
|
|
Jan. 23, 2034
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options valued |
|
|
|
$ 2,461,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares granted |
|
|
|
38,894
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of stock option vested |
|
|
|
38,894
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 Plan [Member] | Equity Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.22%
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
228.00%
|
|
|
|
|
|
2022 Plan [Member] | Stock options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
5.22%
|
|
|
4.40%
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
228.00%
|
|
|
188.00%
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 63.30
|
|
|
$ 63.30
|
|
|
$ 63.30
|
|
|
|
|
|
Number of shares granted |
|
|
|
39,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 Plan [Member] | Stock Option #1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.40%
|
|
|
|
|
|
Volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
188.00%
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.11
|
|
|
|
|
|
Legacy Cardio [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of aggregate shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,334
|
|
|
|
|
|
Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 433,334
|
|
|
|
|
|
Manas former officers and directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares transferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,625,000
|
|
|
|
|
|
Board of directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for services, shares |
|
|
|
|
|
|
|
|
|
|
35,212
|
|
|
|
|
|
251,172
|
|
|
|
|
Stock issued for services, amount |
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
Board of Directors Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for services, shares |
|
|
|
|
|
|
|
|
|
|
1,174
|
|
|
|
|
|
|
|
|
|
|
Stock issued for services, amount |
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
Legacy Cardio Stockholders [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares received |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,883,306
|
|
|
|
|
|
IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
928,571
|
|
|
|
|
|
Private Placement [Member] | 7 accredited investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
561,793
|
|
|
|
|
|
Common stock , per value |
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
$ 0.00001
|
|
|
|
$ 0.00001
|
|
|
|
|
|
Warrant exercise price |
|
|
|
|
|
|
$ 53.40
|
|
|
|
|
$ 53.40
|
|
|
|
$ 1.78
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
18,727
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] | 7 accredited investors [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
561,793
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
18,727
|
|
|
|
|
|
|
|
|
Private Placement [Member] | 7 accredited investors [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
561,793
|
|
|
|
|
|
Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
18,727
|
|
|
|
|
|
|
|
|